Jonathan Harris
Concepts (371)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 21 | 2023 | 762 | 4.410 |
Why?
| | Cystic Fibrosis | 22 | 2023 | 1114 | 3.990 |
Why?
| | Bacteria | 24 | 2023 | 858 | 2.250 |
Why?
| | Respiratory System Agents | 2 | 2022 | 22 | 1.390 |
Why?
| | DNA, Bacterial | 11 | 2021 | 337 | 1.350 |
Why?
| | RNA, Ribosomal, 16S | 20 | 2023 | 549 | 1.330 |
Why?
| | Pseudomonas Infections | 6 | 2023 | 225 | 1.330 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2022 | 652 | 1.260 |
Why?
| | Aminophenols | 2 | 2022 | 156 | 1.220 |
Why?
| | Sputum | 7 | 2020 | 311 | 1.080 |
Why?
| | Metagenome | 8 | 2014 | 147 | 1.070 |
Why?
| | Lung | 12 | 2022 | 4060 | 0.990 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 325 | 0.920 |
Why?
| | Oropharynx | 3 | 2015 | 46 | 0.890 |
Why?
| | Sequence Analysis, DNA | 20 | 2015 | 812 | 0.890 |
Why?
| | RNA, Bacterial | 9 | 2015 | 190 | 0.790 |
Why?
| | Respiratory Tract Infections | 5 | 2023 | 390 | 0.770 |
Why?
| | Pseudomonas aeruginosa | 6 | 2023 | 352 | 0.750 |
Why?
| | Intestines | 3 | 2014 | 357 | 0.730 |
Why?
| | Inflammation | 10 | 2022 | 2837 | 0.730 |
Why?
| | Water Microbiology | 9 | 2018 | 85 | 0.720 |
Why?
| | Phylogeny | 19 | 2016 | 904 | 0.660 |
Why?
| | Respiratory System | 3 | 2016 | 157 | 0.640 |
Why?
| | Biofilms | 6 | 2020 | 260 | 0.620 |
Why?
| | Anti-Bacterial Agents | 9 | 2023 | 1809 | 0.600 |
Why?
| | Polymerase Chain Reaction | 11 | 2015 | 1062 | 0.590 |
Why?
| | Quinolones | 1 | 2020 | 137 | 0.570 |
Why?
| | Trachea | 6 | 2023 | 237 | 0.550 |
Why?
| | Parenteral Nutrition | 2 | 2014 | 107 | 0.500 |
Why?
| | Bronchiectasis | 2 | 2017 | 111 | 0.490 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.490 |
Why?
| | Child | 22 | 2023 | 21935 | 0.480 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2022 | 329 | 0.480 |
Why?
| | Bronchi | 1 | 2016 | 260 | 0.460 |
Why?
| | Bacteria, Anaerobic | 2 | 2011 | 25 | 0.440 |
Why?
| | Metagenomics | 3 | 2022 | 169 | 0.440 |
Why?
| | Deoxyribonuclease I | 1 | 2013 | 39 | 0.420 |
Why?
| | Saliva | 1 | 2015 | 242 | 0.410 |
Why?
| | Staphylococcus aureus | 2 | 2021 | 450 | 0.400 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 234 | 0.390 |
Why?
| | Seawater | 1 | 2012 | 31 | 0.390 |
Why?
| | Chemoradiotherapy | 1 | 2013 | 225 | 0.370 |
Why?
| | Geologic Sediments | 4 | 2008 | 46 | 0.370 |
Why?
| | Humans | 47 | 2023 | 137585 | 0.370 |
Why?
| | Sequence Analysis | 1 | 2011 | 36 | 0.360 |
Why?
| | Eczema | 1 | 2012 | 69 | 0.360 |
Why?
| | Oxygen | 3 | 2020 | 931 | 0.360 |
Why?
| | Molecular Sequence Data | 17 | 2015 | 2900 | 0.360 |
Why?
| | Biodiversity | 8 | 2014 | 409 | 0.340 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 261 | 0.330 |
Why?
| | Age Factors | 1 | 2017 | 3295 | 0.330 |
Why?
| | Gene Library | 1 | 2010 | 118 | 0.320 |
Why?
| | Staining and Labeling | 1 | 2010 | 150 | 0.320 |
Why?
| | Proteomics | 4 | 2022 | 1111 | 0.320 |
Why?
| | Luminescent Measurements | 1 | 2019 | 76 | 0.310 |
Why?
| | Bacteriological Techniques | 1 | 2019 | 73 | 0.310 |
Why?
| | Environmental Microbiology | 3 | 2005 | 53 | 0.310 |
Why?
| | Adolescent | 14 | 2021 | 21513 | 0.300 |
Why?
| | Hypersensitivity | 1 | 2012 | 257 | 0.300 |
Why?
| | Liver | 2 | 2014 | 1943 | 0.300 |
Why?
| | Male | 26 | 2021 | 67762 | 0.290 |
Why?
| | Models, Statistical | 2 | 2016 | 669 | 0.290 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 683 | 0.280 |
Why?
| | Head and Neck Neoplasms | 1 | 2013 | 606 | 0.280 |
Why?
| | Genes, rRNA | 6 | 2012 | 41 | 0.280 |
Why?
| | Cytokines | 2 | 2015 | 2085 | 0.280 |
Why?
| | Legionella | 3 | 2017 | 7 | 0.280 |
Why?
| | Tobramycin | 3 | 2023 | 52 | 0.270 |
Why?
| | Lung Diseases | 2 | 2018 | 767 | 0.270 |
Why?
| | Prospective Studies | 8 | 2023 | 7604 | 0.260 |
Why?
| | Female | 25 | 2021 | 73304 | 0.260 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1040 | 0.260 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 215 | 0.250 |
Why?
| | Drinking Water | 3 | 2017 | 84 | 0.240 |
Why?
| | Endoribonucleases | 3 | 2001 | 81 | 0.240 |
Why?
| | RNA, Archaeal | 3 | 2008 | 16 | 0.240 |
Why?
| | Critical Illness | 3 | 2023 | 811 | 0.230 |
Why?
| | RNA, Catalytic | 3 | 2001 | 187 | 0.230 |
Why?
| | Drug Resistance | 2 | 2017 | 169 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 15 | 0.230 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 346 | 0.220 |
Why?
| | Infant | 7 | 2023 | 9465 | 0.220 |
Why?
| | Azithromycin | 2 | 2023 | 100 | 0.220 |
Why?
| | Evolution, Molecular | 3 | 2005 | 493 | 0.220 |
Why?
| | Air Microbiology | 2 | 2015 | 47 | 0.220 |
Why?
| | Staphylococcus | 5 | 2017 | 76 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2015 | 539 | 0.210 |
Why?
| | Kupffer Cells | 2 | 2014 | 50 | 0.210 |
Why?
| | Biota | 2 | 2015 | 34 | 0.200 |
Why?
| | Premature Birth | 3 | 2017 | 333 | 0.200 |
Why?
| | Young Adult | 8 | 2021 | 13209 | 0.200 |
Why?
| | Genes | 1 | 2003 | 230 | 0.200 |
Why?
| | Respiration, Artificial | 4 | 2023 | 645 | 0.200 |
Why?
| | Smoke | 2 | 2023 | 141 | 0.190 |
Why?
| | Adult | 11 | 2022 | 37929 | 0.190 |
Why?
| | Calreticulin | 1 | 2022 | 28 | 0.190 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.190 |
Why?
| | HMGB Proteins | 1 | 2022 | 18 | 0.190 |
Why?
| | Infant, Newborn | 5 | 2023 | 6079 | 0.190 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 74 | 0.190 |
Why?
| | Administration, Inhalation | 1 | 2023 | 688 | 0.180 |
Why?
| | Archaea | 4 | 2010 | 82 | 0.180 |
Why?
| | Genes, Bacterial | 4 | 2012 | 164 | 0.180 |
Why?
| | Gastritis | 1 | 2022 | 108 | 0.180 |
Why?
| | Mexico | 6 | 2012 | 225 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2017 | 565 | 0.180 |
Why?
| | Enteritis | 1 | 2022 | 103 | 0.180 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 395 | 0.180 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 74 | 0.180 |
Why?
| | Pneumonia, Bacterial | 2 | 2014 | 116 | 0.170 |
Why?
| | Soil Microbiology | 2 | 2015 | 218 | 0.170 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 53 | 0.170 |
Why?
| | Leptin | 1 | 2022 | 236 | 0.170 |
Why?
| | Groundwater | 1 | 2020 | 40 | 0.170 |
Why?
| | Eosinophilia | 1 | 2022 | 218 | 0.170 |
Why?
| | Sweat | 1 | 2020 | 47 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 319 | 0.160 |
Why?
| | Mutation | 2 | 2022 | 3958 | 0.160 |
Why?
| | Proteome | 2 | 2022 | 472 | 0.160 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 383 | 0.160 |
Why?
| | Dysbiosis | 1 | 2021 | 181 | 0.160 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 200 | 0.150 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 257 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 531 | 0.150 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.150 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Ecosystem | 3 | 2010 | 596 | 0.140 |
Why?
| | Case-Control Studies | 4 | 2019 | 3556 | 0.140 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 83 | 0.140 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 10 | 0.140 |
Why?
| | Lipids | 1 | 2022 | 672 | 0.140 |
Why?
| | Nucleic Acid Conformation | 5 | 2005 | 728 | 0.130 |
Why?
| | DNA, Ribosomal | 5 | 2015 | 88 | 0.130 |
Why?
| | Fusobacterium | 1 | 2016 | 2 | 0.130 |
Why?
| | Fusobacterium Infections | 1 | 2016 | 7 | 0.130 |
Why?
| | Haemophilus | 1 | 2016 | 7 | 0.130 |
Why?
| | Eukaryotic Cells | 2 | 2007 | 40 | 0.130 |
Why?
| | Proton Pump Inhibitors | 1 | 2017 | 109 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 64 | 0.120 |
Why?
| | Haemophilus Infections | 1 | 2016 | 42 | 0.120 |
Why?
| | Ribonuclease P | 4 | 2005 | 22 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Esophagitis | 1 | 2016 | 67 | 0.120 |
Why?
| | Biomarkers | 4 | 2020 | 4149 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Child, Preschool | 5 | 2021 | 11074 | 0.120 |
Why?
| | Middle Aged | 6 | 2017 | 33479 | 0.120 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2844 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 84 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Regression Analysis | 1 | 2017 | 1024 | 0.120 |
Why?
| | Pseudomonas | 1 | 2015 | 31 | 0.120 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 40 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.110 |
Why?
| | Plant Oils | 1 | 2014 | 31 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.110 |
Why?
| | Disease Progression | 3 | 2017 | 2757 | 0.110 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.110 |
Why?
| | Bacterial Proteins | 2 | 2016 | 879 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 93 | 0.110 |
Why?
| | Spirometry | 1 | 2015 | 281 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1509 | 0.110 |
Why?
| | Neutrophils | 2 | 2021 | 1238 | 0.110 |
Why?
| | Cyanobacteria | 2 | 2012 | 56 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2020 | 10811 | 0.100 |
Why?
| | Cell Separation | 1 | 2014 | 318 | 0.100 |
Why?
| | Database Management Systems | 1 | 2013 | 51 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.100 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.100 |
Why?
| | Cities | 1 | 2013 | 133 | 0.100 |
Why?
| | Lung Diseases, Interstitial | 1 | 2019 | 638 | 0.100 |
Why?
| | Prednisone | 1 | 2013 | 240 | 0.100 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.100 |
Why?
| | User-Computer Interface | 1 | 2013 | 159 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 255 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 267 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 176 | 0.090 |
Why?
| | DNA | 3 | 2014 | 1459 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 66 | 0.090 |
Why?
| | Asthma | 2 | 2017 | 2295 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 43 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5472 | 0.090 |
Why?
| | Animals | 9 | 2018 | 36940 | 0.090 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2011 | 22 | 0.090 |
Why?
| | Cisplatin | 1 | 2013 | 320 | 0.090 |
Why?
| | Base Sequence | 6 | 2013 | 2181 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2014 | 1178 | 0.090 |
Why?
| | Esophagus | 1 | 2012 | 255 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2018 | 4295 | 0.080 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 400 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1353 | 0.080 |
Why?
| | Mice | 4 | 2014 | 17787 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 273 | 0.080 |
Why?
| | Gastrointestinal Tract | 1 | 2012 | 195 | 0.080 |
Why?
| | Cloning, Molecular | 3 | 2010 | 534 | 0.080 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5757 | 0.070 |
Why?
| | Robotics | 1 | 2010 | 94 | 0.070 |
Why?
| | Genetics, Microbial | 1 | 2008 | 10 | 0.070 |
Why?
| | Double-Blind Method | 1 | 2013 | 1993 | 0.070 |
Why?
| | Salinity | 1 | 2008 | 20 | 0.070 |
Why?
| | Housing | 1 | 2009 | 146 | 0.070 |
Why?
| | Software | 1 | 2013 | 665 | 0.070 |
Why?
| | Methane | 2 | 2020 | 49 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2009 | 297 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 68 | 0.070 |
Why?
| | Genes, Archaeal | 2 | 2005 | 6 | 0.070 |
Why?
| | Ferrets | 2 | 2018 | 27 | 0.070 |
Why?
| | Intestinal Mucosa | 1 | 2012 | 623 | 0.070 |
Why?
| | Smoking | 1 | 2014 | 1627 | 0.070 |
Why?
| | Macrophages | 1 | 2014 | 1547 | 0.060 |
Why?
| | Water | 3 | 2018 | 460 | 0.060 |
Why?
| | Fresh Water | 1 | 2006 | 57 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2008 | 273 | 0.060 |
Why?
| | RNA, Transfer | 2 | 2010 | 138 | 0.060 |
Why?
| | Sodium Chloride | 1 | 2006 | 142 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1946 | 0.060 |
Why?
| | DNA Primers | 2 | 2008 | 515 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 152 | 0.060 |
Why?
| | Sequence Alignment | 2 | 2005 | 343 | 0.060 |
Why?
| | Disinfection | 2 | 2017 | 124 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 910 | 0.050 |
Why?
| | Genetic Variation | 3 | 2009 | 991 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2017 | 201 | 0.050 |
Why?
| | Prokaryotic Initiation Factors | 1 | 2003 | 1 | 0.050 |
Why?
| | Geography | 2 | 2014 | 200 | 0.050 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2003 | 10 | 0.050 |
Why?
| | Genes, Insect | 1 | 2003 | 22 | 0.050 |
Why?
| | Genes, Helminth | 1 | 2003 | 26 | 0.050 |
Why?
| | Nasopharynx | 1 | 2023 | 76 | 0.050 |
Why?
| | Genes, Fungal | 1 | 2003 | 52 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 560 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2023 | 452 | 0.050 |
Why?
| | Archaeal Proteins | 1 | 2003 | 50 | 0.050 |
Why?
| | Databases, Protein | 1 | 2003 | 85 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3284 | 0.050 |
Why?
| | Ribosomal Proteins | 1 | 2003 | 93 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2003 | 123 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2129 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.050 |
Why?
| | Ribosomes | 1 | 2003 | 186 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2017 | 4193 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2023 | 976 | 0.040 |
Why?
| | Quality of Life | 1 | 2013 | 2892 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2003 | 204 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 31 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 786 | 0.040 |
Why?
| | Styrenes | 1 | 2020 | 4 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2003 | 199 | 0.040 |
Why?
| | Colistin | 1 | 2020 | 9 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 861 | 0.040 |
Why?
| | Porphyrins | 1 | 2020 | 23 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 691 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2003 | 465 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2020 | 28 | 0.040 |
Why?
| | Plasmids | 1 | 2001 | 363 | 0.040 |
Why?
| | Methanobacterium | 1 | 1999 | 2 | 0.040 |
Why?
| | Neuroendocrine Cells | 1 | 2019 | 32 | 0.040 |
Why?
| | Bacillus | 1 | 1999 | 16 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4565 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 175 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2020 | 361 | 0.040 |
Why?
| | Aged | 2 | 2017 | 23961 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2003 | 771 | 0.040 |
Why?
| | RNA | 1 | 2005 | 921 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 370 | 0.040 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 37 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 42 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 68 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 66 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2017 | 67 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 1996 | 48 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Escherichia coli | 1 | 2001 | 815 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 78 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2003 | 1164 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 152 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2020 | 2057 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1483 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 190 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 827 | 0.030 |
Why?
| | Conserved Sequence | 2 | 2010 | 239 | 0.030 |
Why?
| | Computational Biology | 2 | 2013 | 644 | 0.030 |
Why?
| | Mucociliary Clearance | 1 | 2015 | 45 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 116 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 118 | 0.030 |
Why?
| | Pregnancy | 2 | 2017 | 6763 | 0.030 |
Why?
| | Nanoparticles | 1 | 2020 | 481 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 102 | 0.030 |
Why?
| | Larynx | 1 | 2014 | 60 | 0.030 |
Why?
| | Birth Weight | 1 | 2017 | 516 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2001 | 2833 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 92 | 0.030 |
Why?
| | New York City | 1 | 2013 | 85 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 547 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2015 | 844 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 42 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 344 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 364 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 574 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 513 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 391 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 58 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 78 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 61 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 849 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 84 | 0.020 |
Why?
| | Suction | 1 | 2011 | 34 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2012 | 189 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 142 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 353 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 600 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1096 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 522 | 0.020 |
Why?
| | Calcium Carbonate | 1 | 2010 | 14 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 391 | 0.020 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 34 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 64 | 0.020 |
Why?
| | Reference Values | 1 | 2012 | 816 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 412 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 318 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 816 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 600 | 0.020 |
Why?
| | Nucleotides | 1 | 2010 | 125 | 0.020 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2015 | 828 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2008 | 17 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 155 | 0.020 |
Why?
| | Risk | 1 | 2011 | 912 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 499 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1129 | 0.020 |
Why?
| | Species Specificity | 1 | 2010 | 585 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 324 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2389 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 886 | 0.020 |
Why?
| | Genetic Code | 1 | 2008 | 22 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 350 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Genome | 1 | 2010 | 300 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1738 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2691 | 0.020 |
Why?
| | Temperature | 1 | 2010 | 679 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2167 | 0.020 |
Why?
| | Proteobacteria | 1 | 2006 | 15 | 0.020 |
Why?
| | Bacteroidetes | 1 | 2006 | 24 | 0.020 |
Why?
| | Chloroflexi | 1 | 2006 | 12 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2847 | 0.020 |
Why?
| | Acanthamoeba castellanii | 1 | 2005 | 2 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2005 | 73 | 0.010 |
Why?
| | Giardia lamblia | 1 | 2005 | 23 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2006 | 317 | 0.010 |
Why?
| | United States | 1 | 2022 | 14841 | 0.010 |
Why?
| | Amino Acids | 1 | 2008 | 497 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2005 | 237 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10388 | 0.010 |
Why?
| | Genomics | 1 | 2005 | 795 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5079 | 0.010 |
Why?
| | Mycoplasma | 1 | 1996 | 5 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1996 | 73 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1996 | 66 | 0.010 |
Why?
| | Kinetics | 1 | 1999 | 1670 | 0.010 |
Why?
| | Models, Molecular | 1 | 1999 | 1570 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2010 | 15657 | 0.010 |
Why?
|
|
Harris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|